New Treatments & Clinical Trials for Esophageal Cancer

Esophageal cancer, which arises in the tube connecting the throat to the stomach, is often caught late because early symptoms are subtle. The two main types are adenocarcinoma, linked to acid reflux and Barrett's esophagus, and squamous cell carcinoma, linked to smoking and alcohol. Treatment typically involves surgery, chemotherapy, and radiation, though outcomes remain challenging for advanced disease.

What's actually going on in research

Trials are testing immunotherapy combinations, particularly checkpoint inhibitors like nivolumab and pembrolizumab, for earlier-stage disease and new treatment sequences. Targeted drugs for HER2-positive tumors and claudin 18.2-positive tumors are in trials. Researchers are also studying less invasive surgery techniques, better radiation methods, and ways to identify cancer earlier in people with Barrett's esophagus.

What to know before you search

Eligibility typically depends on cancer stage, whether it has spread, prior treatments, tumor biomarkers like HER2 or PD-L1 status, and overall health to tolerate treatment.

What types of trials are currently open

• Immunotherapy trials — Testing checkpoint inhibitors alone or with chemotherapy, often for advanced cancer or before surgery. Some trials test combinations of two immunotherapy drugs.
• Targeted therapy trials — Testing drugs that attack specific proteins on cancer cells, such as HER2 or claudin 18.2. Requires tumor testing to see if these proteins are present.
• Surgery trials — Comparing minimally invasive surgery techniques to traditional approaches, or testing whether radiation or chemotherapy before surgery improves outcomes.
• Radiation trials — Testing newer radiation methods, different dose schedules, or combinations with drugs to sensitize tumors to radiation.
• Early detection studies — Tracking people with Barrett's esophagus or other risk factors to find better ways to catch cancer early, when it's easier to treat.